Crawford, looks like inferiority complex and compensation. I hope you are more thorough with the DD you do for investing than you are with your assumption based and over zealous knee jerk snide remarks you toss about so frivolously with the intent to cut down other investors as a means of pumping your self-proclaimed superiority. I know from your post that you are just chomping at the bit while looking for those opportunities. Well, Mr. Wizard, I have over 25 years of experience with stocks. In that time I decided, based on my personal experiences, to lean more of the time toward buy and hold opportunities when presented with them, even in the ETRADE acct. I committed to this stock in that way, long term, and the account in which the vast majority of my shares are held is not day trader friendly for pink sheet investments anyhow. There are limits on trade size and the commissions are high. My ETRADE acct. is day trader friendly, so I have and will continue to play swings with this and many other stocks. I have lost nothing in the larger position unless I panic sell while down and abandon the investment altogether, or the stock skyrockets after I've sold and never returns to previous lows. That possibility is steadily increasing with this stock, and I can't afford to be foolish with the larger account. All big shots have hind sight investing and "I told you so" down pat, and I've seen many lie about their great prophecies based on what we can all see a stock did in the past. I've averaged down using the smaller stake in my ETRADE acct., and the larger acct. may be used that way in the future as large and rapid percentage swings will become less frequent and less likely thereby reducing my risk of being caught with my pants down. I'll try and ignore your insults, if I spot them, in the future. Nor promises though.
Crawford, looks like inferiority complex and compensation.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Arcutis' ZORYVE® Receives Notable Allure Best of Beauty Award
Arcutis' ZORYVE® Celebrated with Allure's Esteemed Award Arcutis Biotherapeutics, Inc. proudly announces that its groundbreaking medication, ZORYVE® (roflumilast), has been awarded the highly esteemed Allure Best of Beauty Breakthrough Award. This recognition marks ZORYVE as a pioneering product, being the first FDA-approved topical treatment for atopic dermatitis,...
Continue Reading
West Monroe Welcomes Accenture's John Rosato as Leader
West Monroe Appoints John Rosato to Transform Technology Division Firm invests to rapidly scale its technology prowess, building on an already strong foundation of experienced capabilities and leadership. West Monroe, a global business and technology consulting firm, is pleased to announce the appointment of John Rosato as its new lead for Technology & Experience. With...
Continue Reading
Gemini Space Station Sets Stage for Public Offering Launch
Gemini Space Station Announces Initial Public Offering Gemini Space Station, Inc. today declared its intention to conduct an initial public offering, offering 16,666,667 shares of Class A common stock as part of a filing submitted to the U.S. Securities and Exchange Commission (SEC). The company aims to solidify its place within the competitive crypto market through this...
Continue Reading
Understanding Public Disclosure of Renewi Plc Ownership
Overview of Public Disclosure in the Context of Renewi Plc The disclosure of ownership positions is crucial under the Takeover Code. Companies, like Renewi Plc, need to comply with strict regulations to inform the public about their shareholders and significant ownership stakes. This article delves into the recent disclosure made by Rathbones Group Plc regarding their...
Continue Reading
Nextracker Investors Alerted on Class Action Lawsuit Updates
Important Update for Nextracker Investors In recent events, Nextracker Inc. has found itself at the center of a class action securities lawsuit, making it crucial for investors to stay informed about their rights and potential actions. This comes from Levi & Korsinsky, LLP, a law firm with significant experience in handling complex securities litigation. Understanding the...
Continue Reading